FOLD - Amicus Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-344,740
-348,995
-284,002
-200,042
-132,118
Depreciation & amortization
4,462
4,216
3,593
3,242
1,833
Deferred income taxes
-
0
-167,305
-3,742
-
Stock based compensation
39,909
29,260
23,101
17,504
9,972
Change in working capital
-7,196
-4,727
-25,787
1,135
14,338
Accounts receivable
-20,756
-13,294
-7,725
-1,419
-
Inventory
-4,172
-4,205
-897
-3,651
-
Accounts Payable
-
-
-
-
-
Other working capital
-264,085
-306,263
-220,011
-156,485
-104,956
Other non-cash items
49,138
14,276
-224,619
14,125
4,884
Net cash provided by operating activites
-253,261
-299,955
-215,485
-150,534
-100,139
Cash flows from investing activities
Investments in property, plant and equipment
-10,824
-6,308
-4,526
-5,951
-4,817
Acquisitions, net
-
-
0
0
-141,060
Purchases of investments
-449,396
-578,394
-490,468
-219,932
-289,595
Sales/Maturities of investments
464,609
463,502
323,753
221,374
290,129
Other investing activites
-
-
-
0
0
Net cash used for investing activites
4,389
-121,200
-171,241
-4,509
-145,343
Cash flows from financing activities
Debt repayment
-293
-334
-308
-80,193
-15,291
Common stock issued
188,994
294,584
243,037
97,068
243,042
Common stock repurchased
-
-2,832
-
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
-
-2,832
-10,000
-18,450
-2,044
Net cash used privided by (used for) financing activities
214,670
450,775
247,434
272,715
290,893
Net change in cash
-34,129
31,138
-137,966
117,541
45,411
Cash at beginning of period
203,830
51,237
187,026
69,485
24,074
Cash at end of period
169,628
82,375
49,060
187,026
69,485
Free Cash Flow
Operating Cash Flow
-253,261
-299,955
-215,485
-150,534
-100,139
Capital Expenditure
-10,824
-6,308
-4,526
-5,951
-4,817
Free Cash Flow
-264,085
-306,263
-220,011
-156,485
-104,956